Research ArticleCancer

Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells

See allHide authors and affiliations

Science Translational Medicine  07 Sep 2016:
Vol. 8, Issue 355, pp. 355ra116
DOI: 10.1126/scitranslmed.aaf8621

Article Information

vol. 8 no. 355 355ra116

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication April 18, 2016
  • Accepted for publication July 21, 2016

Author Information

  1. Cameron J. Turtle1,2,*,
  2. Laïla-Aïcha Hanafi1,
  3. Carolina Berger1,2,
  4. Michael Hudecek1,,
  5. Barbara Pender1,
  6. Emily Robinson1,
  7. Reed Hawkins1,
  8. Colette Chaney1,
  9. Sindhu Cherian3,
  10. Xueyan Chen3,
  11. Lorinda Soma3,
  12. Brent Wood3,
  13. Daniel Li4,
  14. Shelly Heimfeld1,
  15. Stanley R. Riddell1,2, and
  16. David G. Maloney1,2,
  1. 1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  2. 2Department of Medicine, University of Washington, Seattle, WA 98109, USA.
  3. 3Department of Laboratory Medicine, University of Washington, Seattle, WA 98109, USA.
  4. 4Juno Therapeutics, Seattle, WA 98109, USA.
  1. *Corresponding author. Email: cturtle{at}fhcrc.org
    • Present address: Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.

    • These authors contributed equally to this work.

    Altmetric

    Article usage

    Article usage: September 2016 to May 2018

    AbstractFullPdf
    Sep 2016985623653291
    Oct 20161463154356
    Nov 2016919128232
    Dec 201668475143
    Jan 201767953115
    Feb 201761451123
    Mar 20174444380
    Apr 20173292850
    May 20173486470
    Jun 20172916154
    Jul 20173185458
    Aug 20173455857
    Sep 20173395871
    Oct 20173033552
    Nov 20173683752
    Dec 20172782246
    Jan 20183362764
    Feb 20183553377
    Mar 20183273848
    Apr 20183164586
    May 20182662448